177 related articles for article (PubMed ID: 32213734)
21. The syndromes of low-renin hypertension: "separating the wheat from the chaff".
Kater CE; Biglieri EG
Arq Bras Endocrinol Metabol; 2004 Oct; 48(5):674-81. PubMed ID: 15761538
[TBL] [Abstract][Full Text] [Related]
22. Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment.
Turchi F; Ronconi V; di Tizio V; Ceccoli L; Boscaro M; Giacchetti G
Nutr Metab Cardiovasc Dis; 2014 May; 24(5):476-82. PubMed ID: 24630976
[TBL] [Abstract][Full Text] [Related]
23. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A
Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
[TBL] [Abstract][Full Text] [Related]
24. Renal damage in primary aldosteronism: results of the PAPY Study.
Rossi GP; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mannelli M; Matterello MJ; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Pessina AC; Mantero F;
Hypertension; 2006 Aug; 48(2):232-8. PubMed ID: 16801482
[TBL] [Abstract][Full Text] [Related]
25. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
Rossi GP; Belfiore A; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Semplicini A; Agabiti-Rosei E; Pessina AC; Mantero F;
J Hypertens; 2007 Jul; 25(7):1433-42. PubMed ID: 17563566
[TBL] [Abstract][Full Text] [Related]
26. Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography.
Rockall AG; Sohaib SA; Evans D; Kaltsas G; Isidori AM; Monson JP; Besser GM; Grossman AB; Reznek RH
Eur J Endocrinol; 2003 Dec; 149(6):543-8. PubMed ID: 14640995
[TBL] [Abstract][Full Text] [Related]
27. Validation of intimate correlation between visceral fat and hepatic steatosis: Quantitative measurement techniques using CT for area of fat and MR for hepatic steatosis.
Choi MH; Choi JI; Park MY; Rha SE; Oh SN; Jung SE; Byun JY; Kannengiesser S; Son Y
Clin Nutr; 2018 Feb; 37(1):214-222. PubMed ID: 28049553
[TBL] [Abstract][Full Text] [Related]
28. A dispensable role for P450(scc) in the overproduction of aldosterone in aldosterone-producing adenoma and idiopathic hyperaldosteronism in patients with primary aldosteronism.
Fang Y; Zhao L; Zang M; Chen S; Yan F; Di X; Duren A
Pathol Oncol Res; 2010 Dec; 16(4):589-92. PubMed ID: 20066577
[TBL] [Abstract][Full Text] [Related]
29. The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex - a multicenter-study of 3566 Caucasian and Asian subjects.
Spyroglou A; Handgriff L; Müller L; Schwarzlmüller P; Parasiliti-Caprino M; Fuss CT; Remde H; Hirsch A; O'Toole SM; Thuzar M; Petramala L; Letizia C; Deflorenne E; Amar L; Vrckovnik R; Kocjan T; Zhang CD; Li D; Singh S; Katabami T; Yoneda T; Murakami M; Wada N; Inagaki N; Quinkler M; Ghigo E; Maccario M; Stowasser M; Drake WM; Fassnacht M; Bancos I; Reincke M; Naruse M; Beuschlein F
Eur J Endocrinol; 2022 Sep; 187(3):361-372. PubMed ID: 35895721
[TBL] [Abstract][Full Text] [Related]
30. Speckle-Tracking Echocardiographic Layer-Specific Strain Analysis on Subclinical Left Ventricular Dysfunction in Patients With Primary Aldosteronism.
Wang D; Xu JZ; Chen X; Chen Y; Shao S; Zhang W; Zhu LM; Xu TY; Li Y; Wang JG
Am J Hypertens; 2019 Jan; 32(2):155-162. PubMed ID: 30462153
[TBL] [Abstract][Full Text] [Related]
31. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Rossi GP; Bernini G; Caliumi C; Desideri G; Fabris B; Ferri C; Ganzaroli C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Mattarello MJ; Moretti A; Palumbo G; Parenti G; Porteri E; Semplicini A; Rizzoni D; Rossi E; Boscaro M; Pessina AC; Mantero F;
J Am Coll Cardiol; 2006 Dec; 48(11):2293-300. PubMed ID: 17161262
[TBL] [Abstract][Full Text] [Related]
32. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
33. Predictors of confirmatory test results for the diagnosis of primary hyperaldosteronism in hypertensive patients with an aldosterone-to-renin ratio greater than 20. The SHRIMP study.
Okamoto R; Taniguchi M; Onishi Y; Kumagai N; Uraki J; Fujimoto N; Fujii E; Yano Y; Ogura T; Ito M
Hypertens Res; 2019 Jan; 42(1):40-51. PubMed ID: 30401909
[TBL] [Abstract][Full Text] [Related]
34. Comparisons of risk factors for post-treatment renal dysfunction between the two major subtypes of primary aldosteronism.
Watanabe D; Morimoto S; Morishima N; Ichihara A
Endocrine; 2024 Apr; 84(1):245-252. PubMed ID: 38087188
[TBL] [Abstract][Full Text] [Related]
35. Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma.
Rossitto G; Regolisti G; Rossi E; Negro A; Nicoli D; Casali B; Toniato A; Caroccia B; Seccia TM; Walther T; Rossi GP
Hypertension; 2013 Feb; 61(2):526-33. PubMed ID: 23248149
[TBL] [Abstract][Full Text] [Related]
36. Noninvasive estimation of hepatic steatosis in living liver donors: usefulness of visceral fat area measurement.
Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Matsui Y; Togashi J; Ohki T; Yoshida H; Omata M; Makuuchi M; Kokudo N
Transplantation; 2009 Aug; 88(4):575-81. PubMed ID: 19696642
[TBL] [Abstract][Full Text] [Related]
37. Echocardiography and dual-energy x-ray absorptiometry in the elderly patients with metabolic syndrome: a comparison of two different tecniques to evaluate visceral fat distribution.
Stramaglia G; Greco A; Guglielmi G; De Matthaeis A; Vendemiale GL
J Nutr Health Aging; 2010 Jan; 14(1):6-10. PubMed ID: 20082047
[TBL] [Abstract][Full Text] [Related]
38. A novel clinical nomogram to predict bilateral hyperaldosteronism in Chinese patients with primary aldosteronism.
Xiao L; Jiang Y; Zhang C; Jiang L; Zhou W; Su T; Ning G; Wang W
Clin Endocrinol (Oxf); 2019 Jun; 90(6):781-788. PubMed ID: 30820995
[TBL] [Abstract][Full Text] [Related]
39. Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism Among Chinese Population.
Chen Y; Chen X; Chen Q; Yu C
Front Endocrinol (Lausanne); 2021; 12():565714. PubMed ID: 33967948
[TBL] [Abstract][Full Text] [Related]
40. Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease.
Kitajima Y; Eguchi Y; Ishibashi E; Nakashita S; Aoki S; Toda S; Mizuta T; Ozaki I; Ono N; Eguchi T; Arai K; Iwakiri R; Fujimoto K
J Gastroenterol; 2010 Feb; 45(2):218-24. PubMed ID: 19882375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
